Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders.

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders.

Item
http://www.wikidata.org/entity/Q42597272
Current state of renal transplant immunosuppression: Present and futureTranscriptional regulators of claudins in epithelial tight junctionsImproved gastrointestinal symptoms and quality of life after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter studyA four-drug combination therapy consisting of low-dose tacrolimus, low-dose mycophenolate mofetil, corticosteroids, and mizoribine in living donor renal transplantation: A randomized study.Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Random pharmacokinetic profiles of EC-MPS in children with autoimmune disease.Enteric-coated mycophenolate sodium.Enteric-coated mycophenolate sodium in de novo and maintenance kidney-pancreas transplant recipients.The beneficial effect of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids on CMV infection in renal transplant recipients.Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation.Enteric-coated mycophenolate sodium in psoriasis vulgaris: an open pilot study.Mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant patients.Factors leading to dyspepsia in renal transplant recipients.
P2860

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders.

Item
http://www.wikidata.org/entity/Q42597272
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Conversion from mycophenolate ...... trointestinal tract disorders.
@en
Conversion from mycophenolate ...... trointestinal tract disorders.
@nl
type
label
Conversion from mycophenolate ...... trointestinal tract disorders.
@en
Conversion from mycophenolate ...... trointestinal tract disorders.
@nl
prefLabel
Conversion from mycophenolate ...... trointestinal tract disorders.
@en
Conversion from mycophenolate ...... trointestinal tract disorders.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Conversion from mycophenolate ...... trointestinal tract disorders.
@en
P2093
P304
P31
P356
10.1016/J.TRANSPROCEED.2008.07.041
P407
P433
P478
P577
P698